Aldara Cream: Effective Topical Treatment for External Genital Warts
Aldara Cream
| Product dosage: 5% | |||
|---|---|---|---|
| Package (num) | Per tube | Price | Buy |
| 2 | 33.34 $ | 66.69 $ (0%) | 🛒 Add to cart |
| 3 | 31.20 $ | 100.03 $ 93.60 $ (6%) | 🛒 Add to cart |
| 4 | 29.83 $ | 133.38 $ 119.34 $ (11%) | 🛒 Add to cart |
| 5 | 29.25 $ | 166.72 $ 146.25 $ (12%) | 🛒 Add to cart |
| 6 | 28.66 $ | 200.07 $ 171.99 $ (14%) | 🛒 Add to cart |
| 7 | 28.25 $ | 233.41 $ 197.73 $ (15%) | 🛒 Add to cart |
| 8 | 27.93 $ | 266.76 $ 223.47 $ (16%) | 🛒 Add to cart |
| 9 | 27.82 $ | 300.11 $ 250.38 $ (17%) | 🛒 Add to cart |
| 10 | 27.61 $
Best per tube | 333.45 $ 276.12 $ (17%) | 🛒 Add to cart |
Similar products
Aldara Cream is a prescription topical immunotherapy medication containing imiquimod, designed to activate the body’s immune response to combat certain skin conditions. It is clinically proven for the treatment of external genital and perianal warts in adults, offering a non-invasive, self-applied solution that targets the affected area with precision. By stimulating local immune activity, Aldara helps clear visible warts and may reduce the likelihood of recurrence, providing a valuable option in dermatological and sexual health management.
Features
- Contains 5% imiquimod as the active ingredient
- Available in single-use packets or multi-use pump packaging
- Topical cream formulation for easy application
- Requires prescription; not available over-the-counter
- Manufactured under strict pharmaceutical quality standards
- Shelf-stable at recommended storage conditions
Benefits
- Effectively clears external genital and perianal warts through immune activation
- Reduces the risk of wart recurrence compared to some destructive methods
- Allows convenient at-home application, minimizing clinic visits
- Non-invasive treatment alternative to surgical procedures
- Targets only treated areas, minimizing systemic effects
- Supported by extensive clinical research and real-world use
Common use
Aldara Cream is primarily indicated for the treatment of external genital and perianal warts (condylomata acuminata) in adults 18 years and older. It may also be used off-label under medical supervision for certain superficial basal cell carcinomas, actinic keratoses, or other dermatological conditions as determined by a healthcare provider. The cream is applied directly to visible warts, stimulating a localized immune response that helps eliminate abnormal tissue.
Dosage and direction
Apply Aldara Cream to the affected area three times per week (such as Monday, Wednesday, and Friday) before normal sleeping hours. Leave the cream on the skin for 6-10 hours, then wash off with mild soap and water. Use exactly as prescribed by your healthcare provider; typically apply a thin layer to cover the wart area, rubbing in until the cream is no longer visible. Treatment duration is usually until complete clearance of warts or up to 16 weeks, whichever comes first. Do not use more frequently than directed, as increased application may intensify skin reactions without improving efficacy.
Precautions
- For external use only; avoid contact with eyes, lips, nostrils, and mucous membranes
- Do not apply to open wounds or broken skin
- Sexual contact should be avoided while the cream is on the skin
- May weaken condoms and diaphragms; avoid contact with these products
- Wash hands thoroughly before and after application
- Not recommended for use inside the vagina, rectum, or urethra
- Use with caution in patients with autoimmune disorders or those taking immunosuppressive therapy
- May cause local skin reactions including redness, swelling, itching, and erosion
Contraindications
- Hypersensitivity to imiquimod or any component of the formulation
- Not for use in children under 18 years of age
- Should not be used by pregnant women unless clearly needed and benefits outweigh risks
- Avoid use in patients with known immunodeficiencies or organ transplant recipients
- Contraindicated for treatment of internal genital warts (inside vagina, rectum, or urethra)
- Not for use on areas affected by other skin conditions unless directed by a physician
Possible side effects
Common local reactions (occurring in >10% of patients):
- Application site reactions: erythema, edema, itching, burning
- Skin erosion, flaking, scabbing, or ulceration
- Headache, fatigue, muscle aches
- Influenza-like symptoms
Less common reactions (1-10% of patients):
- Back pain, diarrhea, fungal infections
- Increased local pigmentation changes
- Lymph node enlargement near treated area
Rare but serious side effects (<1%):
- Severe skin reactions requiring discontinuation
- Autoimmune disorders exacerbation
- Hypersensitivity reactions including angioedema
Drug interaction
- No formal drug interaction studies have been conducted
- Theoretical potential for interactions with other topical medications applied to the same area
- Possible enhanced effect when used with other immune-stimulating agents
- May affect the efficacy of topical corticosteroids applied concurrently
- Consult your physician about all medications, including over-the-counter products and supplements
Missed dose
If a dose is missed, apply it as soon as remembered unless it is nearly time for the next application. Do not apply two doses closer than 48 hours apart. Do not double the dose to make up for a missed application. Resume the regular three-times-weekly schedule with the next planned application. Consistent application improves treatment efficacy.
Overdose
Topical overdose may result in severe local skin reactions including intense redness, swelling, pain, and ulceration. Systemic absorption is minimal with proper use, but excessive application could potentially increase absorption. If overdose is suspected, wash the area thoroughly with soap and water and seek medical attention. Treatment is symptomatic and supportive. There is no specific antidote for imiquimod overdose.
Storage
Store at room temperature (15-30°C or 59-86°F). Do not freeze. Keep the tube tightly closed when not in use. Store in the original container to protect from light. Keep out of reach of children and pets. Do not use after the expiration date printed on the packaging. Single-use packets should be used immediately after opening; discard any unused portion.
Disclaimer
This information is for educational purposes only and does not replace professional medical advice. Always consult a qualified healthcare provider for diagnosis and treatment recommendations. Individual results may vary. Use only as directed by your physician. The manufacturer is not responsible for misuse or incorrect application.
Reviews
Clinical studies demonstrate complete clearance of external genital warts in 50-80% of patients after 8-16 weeks of treatment. Many patients report satisfaction with the convenience of home application, though most experience local skin reactions that typically resolve after treatment cessation. Dermatologists often note Aldara’s value as a first-line immunotherapy option, particularly for patients preferring non-surgical approaches. Real-world evidence supports its efficacy, though response rates vary based on wart characteristics and patient immune status.